Oyster Point Pharma OYST
$ 11.17
0.0%
Quarterly report 2022-Q3
added 11-10-2022
Oyster Point Pharma Financial Ratios 2011-2024 | OYST
Annual Financial Ratios Oyster Point Pharma
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.8 | -1.2 | -3.2 | - | - | - | - | - | - | - | - |
P/S |
11.7 | - | - | - | - | - | - | - | - | - | - |
EPS |
-3.9 | -2.9 | -10.0 | -11.7 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
216 M | -95.3 M | 13.2 M | 38.7 M | 45.1 M | - | - | - | - | - | - |
EBITDA per Share |
-3.71 | -15.4 | -10.3 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-2.2 | 1.5 | -0.2 | - | - | - | - | - | - | - | - |
PEG |
- | 0.02 | 0.01 | - | - | - | - | - | - | - | - |
P/B |
2.9 | 0.5 | 1.1 | - | - | - | - | - | - | - | - |
P/CF |
-3.2 | -1.5 | -3.6 | - | - | - | - | - | - | - | - |
ROE % |
-101.13 | -37.78 | -33.29 | - | - | - | - | - | - | - | - |
ROA % |
-45.22 | -35.63 | -31.92 | - | - | - | - | - | - | - | - |
ROCE % |
-97.10 | -37.98 | -34.32 | - | - | - | - | - | - | - | - |
Current Ratio |
1.8 | 17.9 | 26.3 | - | - | - | - | - | - | - | - |
DSO |
49.5 | - | - | - | - | - | - | - | - | - | - |
DIO |
728.3 | - | - | - | - | - | - | - | - | - | - |
DPO |
1050.1 | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
777.8 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-272.3 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Oyster Point Pharma
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -1.37 | -1.87 | -1.8 | - | -0.68 | -0.85 | -0.73 | - | -0.63 | -0.66 | -0.77 | - | -8.1 | -7.6 | -2.66 | - | -4.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -1.25 | -1.62 | -1.58 | - | -0.64 | -0.85 | -0.73 | -0.86 | -0.63 | -0.66 | -0.79 | -1.44 | -8.38 | -7.95 | -2.84 | -2.87 | -4.74 | -2.12 | -2.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-383.52 | -396.37 | -574.73 | -125.74 | -38.44 | -50.35 | -46.23 | -40.01 | -37.78 | -40.24 | -39.87 | -39.40 | -33.29 | -8.44 | 17.28 | 35.66 | 50.23 | 39.74 | 22.40 | 11.83 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-95.45 | -104.51 | -79.92 | -58.85 | -32.93 | -44.16 | -43.34 | -37.52 | -35.63 | -38.17 | -37.96 | -37.64 | -31.92 | -88.47 | -196.71 | -189.21 | -186.59 | -116.27 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-325.31 | -334.63 | -496.71 | -108.54 | -34.92 | -46.82 | -46.24 | -40.03 | -38.01 | -40.80 | -40.72 | -40.60 | -34.45 | -9.18 | 16.98 | 35.98 | 51.00 | 40.41 | 22.92 | 12.10 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | 0.8 | 1.1 | 1.5 | 1.8 | 3.4 | 16.6 | 13.1 | 17.6 | 17.6 | 17.6 | 17.6 | 24.2 | 24.2 | 24.2 | 24.2 | 6.0 | 6.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | 196.7 | 161.9 | 209.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | 460.4 | 374.0 | 1382.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | 300.1 | 254.8 | 1234.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 657.1 | 535.9 | 1591.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 357.1 | 281.1 | 356.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency